Nerissa Kreher is Chief Medical Officer of Entrada Therapeutics, Inc.. Currently has a direct ownership of 40,037 shares of TRDA, which is worth approximately $560,518. The most recent transaction as insider was on Sep 06, 2023, when has been sold 892 shares (Common Stock) at a price of $13.73 per share, resulting in proceeds of $12,247. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40K
0% 3M change
3.13% 12M change
Total Value Held $560,518

NERISSA KREHER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 06 2023
SELL
Open market or private sale
$12,247 $13.73 p/Share
892 Reduced 2.18%
40,037 Common Stock
Sep 05 2023
SELL
Payment of exercise price or tax liability
$5,798 $14.46 p/Share
401 Reduced 0.97%
40,929 Common Stock
Sep 01 2023
BUY
Grant, award, or other acquisition
-
14,200 Added 25.57%
41,330 Common Stock
Aug 04 2023
SELL
Open market or private sale
$97,537 $14.14 p/Share
6,898 Reduced 20.27%
27,130 Common Stock
Aug 04 2023
BUY
Exercise of conversion of derivative security
$14,485 $2.1 p/Share
6,898 Added 16.85%
34,028 Common Stock
Aug 03 2023
SELL
Open market or private sale
$139,499 $14.74 p/Share
9,464 Reduced 25.86%
27,130 Common Stock
Aug 03 2023
BUY
Exercise of conversion of derivative security
$19,874 $2.1 p/Share
9,464 Added 20.55%
36,594 Common Stock
Aug 02 2023
SELL
Open market or private sale
$165,257 $15.97 p/Share
10,348 Reduced 27.61%
27,130 Common Stock
Aug 02 2023
BUY
Exercise of conversion of derivative security
$21,730 $2.1 p/Share
10,348 Added 21.64%
37,478 Common Stock
Mar 02 2023
SELL
Payment of exercise price or tax liability
$10,962 $11.6 p/Share
945 Reduced 2.15%
42,971 Common Stock
Mar 02 2023
SELL
Open market or private sale
$17,821 $10.86 p/Share
1,641 Reduced 3.82%
41,330 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
28,400 Added 39.27%
43,916 Common Stock
Dec 30 2022
SELL
Open market or private sale
$69,940 $13.45 p/Share
5,200 Reduced 25.1%
15,516 Common Stock
Oct 26 2022
SELL
Open market or private sale
$107,186 $21.61 p/Share
4,960 Reduced 19.32%
20,716 Common Stock
Oct 26 2022
BUY
Exercise of conversion of derivative security
$10,416 $2.1 p/Share
4,960 Added 16.19%
25,676 Common Stock
Oct 25 2022
SELL
Open market or private sale
$171,734 $21.36 p/Share
8,040 Reduced 27.96%
20,716 Common Stock
Oct 25 2022
BUY
Exercise of conversion of derivative security
$16,884 $2.1 p/Share
8,040 Added 21.85%
28,756 Common Stock
Sep 28 2022
SELL
Open market or private sale
$47,610 $15.25 p/Share
3,122 Reduced 13.1%
20,716 Common Stock
Sep 28 2022
BUY
Exercise of conversion of derivative security
$6,556 $2.1 p/Share
3,122 Added 11.58%
23,838 Common Stock
Sep 27 2022
SELL
Open market or private sale
$36,790 $15.31 p/Share
2,403 Reduced 10.39%
20,716 Common Stock
Sep 27 2022
BUY
Exercise of conversion of derivative security
$5,046 $2.1 p/Share
2,403 Added 9.42%
23,119 Common Stock
Sep 26 2022
SELL
Open market or private sale
$48,413 $15.78 p/Share
3,068 Reduced 12.9%
20,716 Common Stock
Sep 26 2022
BUY
Exercise of conversion of derivative security
$6,443 $2.1 p/Share
3,068 Added 11.43%
23,784 Common Stock
Sep 23 2022
SELL
Open market or private sale
$14,170 $15.09 p/Share
939 Reduced 4.34%
20,716 Common Stock
Sep 23 2022
BUY
Exercise of conversion of derivative security
$1,972 $2.1 p/Share
939 Added 4.16%
21,655 Common Stock

Also insider at

RZLT
Rezolute, Inc. Healthcare
NK

Nerissa Kreher

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Track Activities on TRDA